Table 1.

Patients charecteristics and descriptive statistics

		N	%
Gender	Male	85	42.5%
	Female	115	57.5%
CO-morbidity	No	61	30.5%
	Yes	139	69.5%
Weight loss	No	171	85.5%
	Yes	29	14.5%
DPP4inh Usage	No	107	54.0%
	Yes	93	46.0%
DPP4inh group	Saxagliptin	15	7.5%
	Sitagliptin	45	22.5%
	Vildagliptin	33	16.5%
Arthritis/Arthralgia	No	140	70.0%
	Yes	60	30.0%
Rheumatologic Marker	Negative	182	91.0%
	Positive	18	9.0%